IBM vs REPL · P/E 25, rev $67.53B vs $825.7M cap
International Business Machines (IBM) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported IBM revenue for 2025-12-31 was $67.53B. Net income was $10.59B. Revenue was up 7.6% from 2024-12-31 to 2025-12-31. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
REPL does not have a complete income-statement cache yet.
IBM currently screens at market cap $267.72B and trailing P/E 25.2. REPL currently screens at market cap $825.7M.
Not investment advice. Open the IBM and REPL stock pages for the full models.
Not investment advice.